UBS Group AG - COLLPLANT BIOTECHNOLOGIES LT ownership

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 17 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
UBS Group AG ownership history of COLLPLANT BIOTECHNOLOGIES LT
ValueSharesWeighting
Q3 2023$31,693
-40.7%
5,690
-13.1%
0.00%
Q2 2023$53,432
-4.9%
6,548
-18.2%
0.00%
Q1 2023$56,188
-4.4%
8,004
+13.7%
0.00%
Q4 2022$58,784
-5.2%
7,040
-23.2%
0.00%
Q3 2022$62,000
+3.3%
9,166
+22.0%
0.00%
Q2 2022$60,000
+57.9%
7,514
+119.1%
0.00%
Q1 2022$38,000
-55.8%
3,429
-34.9%
0.00%
Q4 2021$86,000
+100.0%
5,266
+162.0%
0.00%
Q2 2021$43,0002,0100.00%
Other shareholders
COLLPLANT BIOTECHNOLOGIES LT shareholders Q1 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 597,662$6,837,00011.05%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 444,444$4,987,0000.88%
VILLERE ST DENIS J & CO LLC 265,997$2,984,0000.18%
FNY Investment Advisers, LLC 5,000$57,0000.05%
BENJAMIN F. EDWARDS & COMPANY, INC. 75,270$861,0000.04%
ARK Investment Management 228,657$2,566,0000.01%
BROWN ADVISORY INC 77,349$868,0000.00%
UBS Group AG 3,429$38,0000.00%
OSAIC HOLDINGS, INC. 248$3,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 3,600$40,0000.00%
View complete list of COLLPLANT BIOTECHNOLOGIES LT shareholders